COVID-19 Hits Black MS Patients Hard
— COViMS registry gives first look at outcomes among North American patients by Judy George, Senior Staff Writer, MedPage Today September 28,…
“Discontinuation of disease-modifying treatments in multiple sclerosis to plan a pregnancy”
Abstract Background: For safety reasons multiple sclerosis (MS) treatment guidelines recommend stopping or delaying the onset of disease-modifying therapies (DMT) before…
Stuart Schlossman
Updated Atlas of MS Shows Over 2.8 Million People Worldwide Have Multiple Sclerosis — with Nearly 1 Million in the US
September 11, 2020 There are now 2.8 million people worldwide who have multiple sclerosis (MS), according to the most extensive…
Stuart Schlossman
“Of all these cognitive challenges, it is the slowing of information processing speed that is considered the cardinal cognitive difficulty linked to MS.”
September 2020 written by: Anthony Feinstein MPhil, PhD, FRCP, Professor, Department of Psychiatry …
Stuart Schlossman
What Is Clinically Isolated Syndrome and Will It Turn Into Multiple Sclerosis?
What is clinically isolated syndrome (CIS)? Clinically isolated syndrome (CIS) is an episode of neurologic symptoms. CIS involves demyelination in your central…
Stuart Schlossman
Stephen L. Hauser, MD: Increasing Understanding of Disease Progression in MS
September 23, 2020 The director of the UCSF Weill Institute for Neuroscience spoke to the advantages of having agents that…
Stuart Schlossman
Registration open for our next Virtual ‘Compass to MS Care’ Rural America and Beyond, event – on 9/22/20
RSVP , by clicking here, for: A Compass to MS Care event on 9/22 at 6:10pm ET — with Dr.…
Stuart Schlossman
Does obesity exacerbate brain lesion volume and atrophy in patients with multiple sclerosis?
Click HERE to Subscribe for the MS Beacon Newsletter Rachel Galioto 1, Ophira Berenholz 2, Zhini Wang 3, Devon S Conway 4, Sarah M Planchon 4, Stephen M Rao 5 Affiliations expand…
Stuart Schlossman
Bristol-Myers Squibb works to achieve the mission of transforming patients’ lives through science. Introducing a Patient Expert Engagement Resource (PEER)
BMS.com would like to share a new article and video highlighting Patient Expert Engagement Resource (PEER) and featuring quotes and footage from…
Stuart Schlossman
More on the FDA Approval of Kesimpta, B-cell Targeting Therapy for Relapsing MS
The U.S. Food and Drug Administration (FDA) has approved Novartis‘ Kesimpta (ofatumumab) as a self-administered treatment for adults with relapsing forms of multiple sclerosis (MS),…
Stuart Schlossman
